Kevin McCulloch - President and Chief Operating Officer at Xeris Biopharma Holdings, Inc.

Insider Transactions and Holdings

Entity Type: Individual
Role: President and Chief Operating Officer
Issuer Symbol: XERS on Nasdaq
All Insider Reports: All Insider Reports

Kevin McCulloch - trading volume in the past year for Xeris Biopharma Holdings, Inc.

	Shares	%	Avg Price	Total $
Buys	+25,000	62%	$4.38	+$109,475
Sells	-15,000	38%	$8.00	-$120,000
Net	+10,000	25%		-$10,525

Holdings reported by Kevin McCulloch for Xeris Biopharma Holdings, Inc.

Security	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	1,727,827	$12,716,806	$7.36	31 Jan 2026	Direct
Common Stock	25,000	$196,250	$7.85	30 Jan 2026	By Spouse
Stock Appreciation Right	500,000			31 Jan 2025	Direct	Common Stock
Stock Option (Right to Buy)	225,225			30 Jan 2026	Direct	Common Stock

Transactions reported by Kevin McCulloch for Xeris Biopharma Holdings, Inc.

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.